Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial - Wikidata - wikimedia - TriplyDB

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial

http://www.wikidata.org/entity/Q28543146

about

Antimalarial drugs for preventing malaria during pregnancy and the risk of low birth weight: a systematic review and meta-analysis of randomized and quasi-randomized trials Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy Factors Associated with Retention to Care in an HIV Clinic in Gabon, Central Africa Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Control Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections.Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria Effects of HIV infection on maternal and neonatal health in southern Mozambique: A prospective cohort study after a decade of antiretroviral drugs roll out.Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities Malaria prevention during pregnancy-is there a next step forward?Antimalarial compounds in Phase II clinical development.Malaria in Pregnancy Is a Predictor of Infant Haemoglobin Concentrations during the First Year of Life in Benin, West Africa A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya Does Iron Increase the Risk of Malaria in Pregnancy?Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.Demography, maternal health and the epidemiology of malaria and other major infectious diseases in the rural department Tsamba-Magotsi, Ngounie Province, in central African Gabon Soluble human leukocyte antigen -G during pregnancy and infancy in Benin: Mother/child resemblance and association with the risk of malaria infection and low birth weight.Infant mortality and morbidity associated with preterm and small-for-gestational-age births in Southern Mozambique: A retrospective cohort study Malaria during Pregnancy.Streptococcus agalactiae Serotype Distribution and Antimicrobial Susceptibility in Pregnant Women in Gabon, Central Africa Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an op The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections Elevated Blood Lead Levels in Infants and Mothers in Benin and Potential Sources of Exposure Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.Young adolescent girls are at high risk for adverse pregnancy outcomes in sub-Saharan Africa: an observational multicountry study.Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trial.Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data.Congenital and perinatally-acquired infections in resource-constrained settings.Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.Prevention and control of malaria in pregnancy - new threats, new opportunities?The Challenge of Assessing Microcephaly in the Context of the Zika Virus Epidemic.High Iron Levels Are Associated with Increased Malaria Risk in Infants during the First Year of Life in Benin.Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens.Mefloquine for preventing malaria during travel to endemic areas.Management of malaria in pregnancy.Four artemisinin-based treatments in African pregnant women with malaria.

P2860

Q26798114-A2D93849-81FC-4618-9E9F-E5DB2456522E Q28543154-8CBE7004-0E7D-4698-A050-2A94EB9AA44E Q28546725-2D4368CF-B5C6-4016-90A6-8407E39A12A7 Q28550345-23284BB2-0EB4-42C8-A13C-BAB0608F6FF6 Q28550346-8F2653EA-0F52-4236-9A37-F9B0553E3BC5 Q28554025-4B738E0D-700A-4338-938E-D8590DAB69B0 Q33589254-4141B6D2-537F-442C-86ED-C031AAFE8F5C Q33696767-003A2235-0AFF-4C69-A331-2CEB233AC4AB Q33757461-95125314-E556-458A-9C7C-DFCD01763FED Q33910163-7680D1ED-A3F0-4381-844A-18388C665B39 Q34231478-C83E4C62-93E8-4C4B-B873-477B4E327905 Q34456807-9691817A-CC3F-467D-8673-FECBED7791B5 Q35656026-4ADBE327-0BFE-4395-90E5-419EF89D9DFA Q35741292-339ADC8C-ACE0-47EC-9C68-8249701C9BE4 Q35933939-4CB76093-2927-4CBB-A530-9FB3F1ED6410 Q35960893-88BEF47E-B9EC-40CB-97AA-1AB8602B6060 Q36051953-5DA04721-2211-4F63-B212-D35F6FDFD3B3 Q36057593-092AF87A-94E3-409A-982C-045A912C4F81 Q36094714-AD860B14-9A57-4BEB-9CF2-8ED9DE8C9DEC Q36262884-D915A128-DFA2-4EE1-A79B-B2E0DFCF9A0B Q36271612-E24D1D4B-1FE7-4E55-B527-8820CE0F2B19 Q36284085-CB5AD97D-B5C5-436C-A850-B28F77ACA37B Q36284603-E61B63B5-A170-4C5A-9343-870EE06C35BF Q36316713-1930069E-DCAF-4C25-81BB-F3522D163D85 Q36478633-E43B1D4C-A528-466E-9969-D1F5452CC37E Q36676359-CAD69FB0-9146-4CF4-A640-A37F7520AF63 Q36732502-FF401150-6ED5-4A35-B581-80692829AE5B Q36843561-C9A63BDC-0A5D-4282-A382-4579D9793A83 Q37063702-AF91B7B4-D8EF-43C8-B139-A7DF63D77E64 Q37280776-41D52E15-36B9-4C65-9882-25AC5A6B62B4 Q38632443-925CFF6B-5997-424C-A59D-7E8664484ABF Q38904188-8620EBCD-82D6-413F-B532-D85398F37A90 Q38931390-7504240B-73B2-4909-A4ED-7E1A4657E3E4 Q39038490-B294DFFF-61CA-4F02-B58A-5CFBDCAD4492 Q39375377-1570EBC3-C1D0-4E46-AC51-5108F45A5BB0 Q40117098-1572AC3F-BB9F-438C-A8EF-E7207886E60C Q40120062-997169B2-6628-42D3-AB22-503AB69EF7C1 Q47140318-14F1C3F1-80B7-4655-A693-F2774A30B5C1 Q47797899-EB6A8479-219E-4FD9-A442-497C39FF0704 Q53658119-AA47FF1F-2C07-4758-8D6A-25BAF6C62009

P2860

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial

http://www.wikidata.org/entity/Q28543146

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Intermittent preventive treatm ...... re randomized controlled trial

@ast

Intermittent preventive treatm ...... re randomized controlled trial

@en

Intermittent preventive treatm ...... re randomized controlled trial

@nl

type

label

Intermittent preventive treatm ...... re randomized controlled trial

@ast

Intermittent preventive treatm ...... re randomized controlled trial

@en

Intermittent preventive treatm ...... re randomized controlled trial

@nl

prefLabel

Intermittent preventive treatm ...... re randomized controlled trial

@ast

Intermittent preventive treatm ...... re randomized controlled trial

@en

Intermittent preventive treatm ...... re randomized controlled trial

@nl

P1433

Q28543146-06CA3E92-6C70-41FF-9CDD-525D53A25A74

P1476

Q28543146-1EE2EAE6-F9FA-4EC1-88F1-27FABEE9BF15

P2093

Q28543146-15606F86-2973-483A-971C-7E00D5DDA969

Q28543146-19780D10-2A09-4D22-AE19-415744508C91

Q28543146-2DF4B7CE-D975-4777-BAC9-FA34DC6EE6B3

Q28543146-2EF098DD-31A2-4639-BD1C-B119166DD629

Q28543146-33583CF9-8022-429B-96BD-3AC07227345E

Q28543146-499D4C0D-BF9C-4D39-80DC-A9B0641CD6C7

Q28543146-506C3795-DAB3-41FD-A7A3-A8BBBCE8E3F8

Q28543146-A10E8B7A-3293-4E44-8A26-9B20EE0F59E0

Q28543146-A1AAB1DB-0411-4493-8143-528A9842890F

Q28543146-B0C92AD2-7A2A-4E6E-9EEF-616B5532999A

P2860

Q28543146-04A32D7F-3840-473E-A200-130368B37A00

Q28543146-06D2CFAD-D953-4474-8A54-360D58752AD7

Q28543146-0A24A20B-7D14-49EF-AFA7-7BB6D3768334

Q28543146-13CB76F0-18BE-445D-988E-4D5F8FC76832

Q28543146-1605913E-D918-49F3-8592-534A2C0BA91C

Q28543146-192BCAD0-197A-464E-98BC-A2E6EFC7A3DA

Q28543146-230AC895-E220-4846-9D5C-9202E9DC7CB2

Q28543146-25DF3EFC-256F-40E2-8654-9463D5932FAA

Q28543146-300D63AF-2D78-4535-BFEE-A3DABFB4B214

Q28543146-30EDE4D7-98EA-4349-A715-9ED4BE62EC44

P304

Q28543146-8CD3CE79-E505-4E90-9CD7-35662EDE3731

P31

Q28543146-60EBB8D9-8A3A-4A19-A1FF-B16C057D24A8

P3181

Q28543146-5A3874A9-3F4F-4C11-9281-BB2A33775C99

P356

Q28543146-8A49DAB7-3C9D-44EA-96B9-0B23EE65FFB8

P407

Q28543146-B217EA67-25BD-48E2-BA5F-70D72E4BC76C

P433

Q28543146-C41915CC-B578-4859-A053-6DB928214BD6

P478

Q28543146-336B8F71-D498-45C5-BC02-A7FCDB868878

P50

Q28543146-30B3ACB5-715A-474E-BC8F-4026FB3CB296

Q28543146-3814A273-DF05-4EF2-AF71-480FE74F223A

Q28543146-9B89E29D-8C6F-4139-9984-3B6721177293

Q28543146-B65B2999-4806-4EC7-AAA1-6F2E1CF941D1

Q28543146-C965E58B-453F-4645-92A0-9E8194DEE460

Q28543146-E0FB9E39-0D69-438E-8834-438BD4A4F931

P577

Q28543146-C71CB7F1-2E05-43E7-A390-6F201B88F191

P698

Q28543146-84B424D2-A8ED-4498-B3A2-1303AB2C5AA1

P921

Q28543146-2FAB37B4-F4CD-4AA4-A832-5122D335F104

Q28543146-32B2497D-1AEE-4FFC-923F-E0092D591163

Q28543146-52942711-EAD6-41C9-B57A-8F083E221BA9

Q28543146-5D1ED83C-3133-4EE9-9CEF-0125E83A85AE

P932

Q28543146-F3AA3418-C44F-435C-ACA7-B1D0AC70428B

P3181

P356

JOURNAL.PMED.1001733

P1433

P1476

Intermittent preventive treatm ...... re randomized controlled trial

@en

P2093

Abdunoor M Kabanywanyi

http://www.w3.org/2001/XMLSchema#string

Achille Massougbodgi

http://www.w3.org/2001/XMLSchema#string

Alfredo Mayor

http://www.w3.org/2001/XMLSchema#string

Anifa Vala

http://www.w3.org/2001/XMLSchema#string

Arsenio Nhacolo

http://www.w3.org/2001/XMLSchema#string

Arti Basra

http://www.w3.org/2001/XMLSchema#string

Christian Kleine

http://www.w3.org/2001/XMLSchema#string

Daisy Akerey-Diop

http://www.w3.org/2001/XMLSchema#string

Esperança Sevene

http://www.w3.org/2001/XMLSchema#string

Eusebio Macete

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis of Plasmodium falciparum Malaria at Delivery: Comparison of Blood Film Preparation Methods and of Blood Films with Histology

The position of mefloquine as a 21st century malaria chemoprophylaxis

Mefloquine safety and tolerability in pregnancy: a systematic literature review

Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy

An analysis of malaria in pregnancy in Africa

Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients

Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial

A modified poisson regression approach to prospective studies with binary data

Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.

P304

e1001733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

405130

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.1001733

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Michael Ramharter

Peter Gottfried Kremsner

Clara Menéndez

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25247709

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

pregnancy-associated malaria

P932

4172436

http://www.w3.org/2001/XMLSchema#string